|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0009452,
umls-concept:C0013089,
umls-concept:C0021735,
umls-concept:C0205054,
umls-concept:C0205210,
umls-concept:C0205373,
umls-concept:C0221464,
umls-concept:C0699666,
umls-concept:C0871261,
umls-concept:C1521733,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2239176,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-4-15
|
|
pubmed:abstractText |
The case described here illustrates the antitumor activity of a four-drug systemic combination chemobiotherapy with platinol, recombinant interferon alpha 2b, doxorubicin (Adriamycin), and 5-fluorouracil (5-FU) (PIAF) in a patient with diffuse hepatocellular carcinoma involving the liver and lungs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0277-3732
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
209-13
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10199464-Aged,
pubmed-meshheading:10199464-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10199464-Carcinoma, Hepatocellular,
pubmed-meshheading:10199464-Cisplatin,
pubmed-meshheading:10199464-Doxorubicin,
pubmed-meshheading:10199464-Female,
pubmed-meshheading:10199464-Fluorouracil,
pubmed-meshheading:10199464-Hepatic Artery,
pubmed-meshheading:10199464-Humans,
pubmed-meshheading:10199464-Infusions, Intra-Arterial,
pubmed-meshheading:10199464-Interferon-alpha,
pubmed-meshheading:10199464-Liver Neoplasms,
pubmed-meshheading:10199464-Recombinant Proteins
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication.
|
|
pubmed:affiliation |
Department of Gastrointestinal Medical Oncology and Digestive Diseases, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
